-
-
-
-
-
-
-
Carlyle, SK Capital Partners and bluebird bio (BLUE) Amend Merger Agreement
-
-
-
-
-
-
-
bluebird bio (BLUE) Confirms Receipt of an Unsolicited Non-Binding Proposal from Ayrmid
-
-
-
-
-
-
-
Midday movers: Lululemon, Paramount and more
-
-
-
-
-
-
-
Bluebird Bio and Resilience Announce Strategic Alliance to Develop Next Generation Cell Therapies
-
-
-
-
-
-
-
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against bluebird bio, EHang, fuboTV and Jianpu Technology Encourages Investors to Contact the Firm
-
-
-
-
-
-
-
Bristol Myers Squibb (BMY), bluebird (BLUE) Announce FDA Accepts for Priority Review Application for Anti-BCMA CAR T Cell Therapy Idecabtagene Vicleuce
-
-
-
-
-
-
-
UPDATE: SVB Leerink Downgrades bluebird bio (BLUE) to Market Perform
-
1,122,779 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

